These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The effect of aerosolization on the changes in major biological properties of the vaccine strain of Francisella tularensis]. Koniukhov VF; Petrosov VV; Meshcheriakova IS; Savel'eva RA Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):26-9. PubMed ID: 6613417 [TBL] [Abstract][Full Text] [Related]
27. Tularemia: the disease and the weapon. Cronquist SD Dermatol Clin; 2004 Jul; 22(3):313-20, vi-vii. PubMed ID: 15207312 [TBL] [Abstract][Full Text] [Related]
28. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351 [No Abstract] [Full Text] [Related]
29. [Present-day status of tularemia prevention in the USSR and further tasks]. Nikolaevskiĭ GP; Frolov VI; Morozov VI Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):104-9. PubMed ID: 746999 [TBL] [Abstract][Full Text] [Related]
30. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model. Stinson E; Smith LP; Cole KS; Barry EM; Reed DS Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27511964 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of immunobiological activity of Francisella tularensis C-complex preparations as promising component of subunit vaccines]. Volokh OA; Shepelev IA; Firsova VV; Khramkova EM; Avdeeva NG; Samokhvalova IuI; Eremin SA; Diatlov IA; Zhemchugov VE Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):16-21. PubMed ID: 17672125 [TBL] [Abstract][Full Text] [Related]
33. [Present-day problems of natural foci and the prevention of tularemia]. Olsuf'ev NG Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):3-8. PubMed ID: 506600 [No Abstract] [Full Text] [Related]
34. [Remote hyperergic-allergic reactions of the skin following tularemia vaccination]. Pototskiĭ II Vestn Dermatol Venerol; 1967 Feb; 41(2):81-2. PubMed ID: 5620485 [No Abstract] [Full Text] [Related]
35. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Shen H; Chen W; Conlan JW Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850 [TBL] [Abstract][Full Text] [Related]
36. [Comparative study of the reactogenicity and immunogenicity of various doses of a chemical polysaccharide meningococcal vaccine administered by syringe and jet injector]. Pavlova LI; Nefedova LA; Nikitiuk NM; Chernysheva TF; Alliluev AP Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):58-64. PubMed ID: 6419514 [TBL] [Abstract][Full Text] [Related]
37. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170 [TBL] [Abstract][Full Text] [Related]
38. [Aerosol vaccination against dangerous infectious diseases]. Stepanov AV; Marinin LI; Vorob'ev AA Vestn Ross Akad Med Nauk; 1999; (8):47-54. PubMed ID: 10487124 [TBL] [Abstract][Full Text] [Related]
39. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia. Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944 [TBL] [Abstract][Full Text] [Related]
40. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]